Ceftazidime 500 mg powder for solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

ceftazidime 500 mg powder for solution for injection

hikma farmacêutica (portugal) s.a. - ceftazidime - powder for solution for injection - 500 milligram(s) - third-generation cephalosporins; ceftazidime

Ceftazidime 1g Powder for solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

ceftazidime 1g powder for solution for injection

wockhardt uk limited - ceftazidime - powder for solution for injection/infusion - 1 gram(s) - third-generation cephalosporins; ceftazidime

Ceftazidime 2g Powder for solution for injection or infusion Ireland - English - HPRA (Health Products Regulatory Authority)

ceftazidime 2g powder for solution for injection or infusion

wockhardt uk limited - ceftazidime - powder for solution for injection/infusion - 2 gram(s) - third-generation cephalosporins; ceftazidime

Ceftazidime 1 g powder for solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

ceftazidime 1 g powder for solution for injection/infusion

hikma farmacêutica (portugal) s.a. - ceftazidime - powder for solution for injection/infusion - 1 gram(s) - third-generation cephalosporins; ceftazidime

Ceftazidime 2 g powder for solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

ceftazidime 2 g powder for solution for injection/infusion

hikma farmacêutica (portugal) s.a. - ceftazidime - powder for solution for injection/infusion - 2 gram(s) - third-generation cephalosporins; ceftazidime

FORTAZ- ceftazidime injection, powder, for solution United States - English - NLM (National Library of Medicine)

fortaz- ceftazidime injection, powder, for solution

teligent pharma, inc. - ceftazidime (unii: 9m416z9qnr) (ceftazidime anhydrous - unii:dzr1ent301) - ceftazidime anhydrous 200 mg in 1 ml - fortaz is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: fortaz may be used alone in cases of confirmed or suspected sepsis. ceftazidime has been used successfully in clinical trials as empiric therapy in cases where various concomitant therapies with other antibacterial drugs have been used. fortaz may also be used concomitantly with other antibacterial drugs, such as aminoglycosides, vancomycin, and clindamycin; in severe and life-threatening infections; and in the immunocompromised patient. when such concomitant treatment is appropriate, prescribing information in the labeling for the other antibacterial drugs should be followed. the dose depends on the severity of the infection and the patient's condition. to reduce the development of drug-resistant bacteria and maintain the effectiveness of fortaz and other antibacterial drugs, fortaz should be used only to treat infections that are proven or strongly suspected

Ceftazidime 1g Powder for solution for injection or infusion Ireland - English - HPRA (Health Products Regulatory Authority)

ceftazidime 1g powder for solution for injection or infusion

pinewood laboratories ltd - ceftazidime - powder for solution for injection/infusion - 1 gram(s) - third-generation cephalosporins; ceftazidime

Ceftazidime 2g Powder for solution for injection or infusion Ireland - English - HPRA (Health Products Regulatory Authority)

ceftazidime 2g powder for solution for injection or infusion

pinewood laboratories ltd - ceftazidime - powder for solution for injection/infusion - 2 gram(s) - third-generation cephalosporins; ceftazidime

CEFTAZIDIME FOR INJECTION, USP POWDER FOR SOLUTION Canada - English - Health Canada

ceftazidime for injection, usp powder for solution

fresenius kabi canada ltd - ceftazidime - powder for solution - 1g - ceftazidime 1g - third generation cephalosporins